Study reveals brain structure variability in schizophrenia

The first day of the JP Morgan Healthcare Conference held in San Francisco, California from 13 January to 15 January 2025 began with Johnson &

No­vo Nordisk’s GLP-1 drugs may have been the cen­ter of at­ten­tion dur­ing its first-quar­ter earn­ings call, but the com­pa­ny’s broad­er di­a­betes port­fo­lio beat its tar­get

Adding liposome-encapsulated irinotecan to standard chemotherapy failed to improve survival as second-line treatment for advanced biliary cancer, a small randomized study showed. Median progression-free survival